Filing Details
- Accession Number:
- 0001209191-22-009370
- Form Type:
- 5
- Zero Holdings:
- No
- Publication Time:
- 2022-02-14 16:56:21
- Reporting Period:
- 2021-12-31
- Accepted Time:
- 2022-02-14 16:56:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1720580 | Adicet Bio Inc. | ACET | Pharmaceutical Preparations (2834) | 813305277 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1823901 | Aya Jakobovits | C/O Adicet Bio, Inc. 200 Clarendon Street, Floor 6 Boston MA 02116 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-12-22 | 7,000 | $16.02 | 332,552 | No | 4 | S | Indirect | See Footnote |
| Common Stock | Disposition | 2021-12-22 | 7,000 | $16.03 | 332,553 | No | 4 | S | Indirect | See Footnote |
| Common Stock | Disposition | 2021-12-23 | 109,488 | $0.00 | 0 | No | 5 | G | Indirect | See Footnote |
| Common Stock | Acquisiton | 2021-12-23 | 29,905 | $0.00 | 138,076 | No | 5 | G | Indirect | See Footnote |
| Common Stock | Acquisiton | 2021-12-23 | 39,791 | $0.00 | 372,343 | No | 5 | G | Indirect | See Footnote |
| Common Stock | Acquisiton | 2021-12-23 | 39,792 | $0.00 | 372,345 | No | 5 | G | Indirect | See Footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | See Footnote |
| No | 4 | S | Indirect | See Footnote |
| No | 5 | G | Indirect | See Footnote |
| No | 5 | G | Indirect | See Footnote |
| No | 5 | G | Indirect | See Footnote |
| No | 5 | G | Indirect | See Footnote |
Footnotes
- These sales were effected pursuant to Rule 10b5-1 trading plans previously adopted by the Reporting Person.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.46 to $16.34. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- Shares held in a trust of which Dr. Jakobovits' spouse is the trustee and Dr. Jakobovits' daughter is the beneficiary.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.47 to $16.34. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- Shares held in a trust of which Dr. Jakobovits' spouse is the trustee and Dr. Jakobovits' son is the beneficiary.
- Represents a gift of Common Stock made on December 23, 2021.
- Shares transferred from a grantor retained annuity trust ("GRAT") of which Dr. Jakobovits' spouse is the trustee and Dr. Jakobovits the sole annuitant and current beneficiary. Following this transaction, this GRAT was terminated.
- Shares held in a revocable trust of which Dr. Jakobovits and her spouse are co-trustees.
Billionaire Hedge Funds
